James D. Marks (Chairman), MD, Ph.D.
Professor of Anesthesia and Pharmaceutical Chemistry at University of California (San Francisco, USA).

Daniel Levitt, M.D., Ph.D. 
Vice President and Chief Medical Officer of Dynavax Technologies (Palo Alto, USA).

Stanley Falkow, Ph.D.
Professor of Microbiology and Immunology at Stanford University School of Medicine
(Palo Alto, USA).

Harry B. Greenberg, M.D.
Professor of Medicine and Microbiology and Immunology at Stanford University School of Medicine (Palo Alto, USA).

Ronald Levy, M.D.
Professor of medicine and chief of division of oncology at the Stanford University School of Medicine (Palo Alto, USA)

Henrik S. Rasmussen, M.D., Ph.D.
Vice President of Clinical, Medical and Regulatory Affairs at Novo Nordisk (New Jersey, USA)